Does DUPILUMAB Cause Type iii immune complex mediated reaction? 13 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Type iii immune complex mediated reaction have been filed in association with DUPILUMAB (Dupixent). This represents 0.0% of all adverse event reports for DUPILUMAB.
13
Reports of Type iii immune complex mediated reaction with DUPILUMAB
0.0%
of all DUPILUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Type iii immune complex mediated reaction From DUPILUMAB?
Of the 13 reports, 2 (15.4%) required hospitalization.
Is Type iii immune complex mediated reaction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DUPILUMAB. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does DUPILUMAB Cause?
Pruritus (44,279)
Dermatitis atopic (33,670)
Product use in unapproved indication (33,452)
Rash (30,895)
Injection site pain (27,799)
Drug ineffective (23,712)
Dry skin (20,239)
Eczema (20,020)
Product dose omission issue (18,189)
Condition aggravated (16,459)
What Other Drugs Cause Type iii immune complex mediated reaction?
RITUXIMAB (25)
VANCOMYCIN (24)
HUMAN IMMUNOGLOBULIN G (23)
OXALIPLATIN (23)
METHOTREXATE (19)
MYCOPHENOLATE MOFETIL (18)
TACROLIMUS (18)
CYCLOPHOSPHAMIDE (17)
BORTEZOMIB (16)
CYCLOSPORINE (16)
Which DUPILUMAB Alternatives Have Lower Type iii immune complex mediated reaction Risk?
DUPILUMAB vs DURAGESIC
DUPILUMAB vs DUROGESIC
DUPILUMAB vs DUROTEP MT
DUPILUMAB vs DURVALUMAB
DUPILUMAB vs DUTASTERIDE